{"nct_id":"NCT03054428","title":"Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2017-03-21","start_date_type":"ACTUAL","primary_completion_date":"2018-04-04","primary_completion_date_type":"ACTUAL","completion_date":"2018-06-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["REGN"]}